Atlas Trials

A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants

Clinical trial NCT04004988 · COMPLETED

Trial details

NCT number
NCT04004988
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2019-08-19
Primary completion
2019-12-16
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.